The Federated Biomarker Explorer eases data feasibility by allowing pharma teams to assess biomarker presence early without integration or IT support needed.

Pharma teams can now assess biomarker coverage across datma’s federated network with no cost, contracts, or IT support required. datma, a leader in federated real-world data access, today announced the launch of the Federated Biomarker Explorer, a new application that allows pharmaceutical teams to evaluate real-world biomarker coverage across d

read more